February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
January 10, 2018 | Regulatory Virtualization Poses Risks to Data Integrity in Clinical Trials Stephanie Colotti Senior Partner, Validant 3 Minute Read